ABACUS MEDICINE A/S: Financial statements 2025
CVR: 28111576
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ABACUS MEDICINE A/S (CVR 28111576) has filed annual accounts for 2025. In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. That is an increase of 22.2% compared with the year before. The profit margin was 0.4%. Equity in the 2025 report amounted to EUR 98,523,000. The solvency ratio was 19.9%. The company had 1,590 employees in the financial year.
- Revenue
- EUR 1,817,637,000
- Gross Profit
- EUR 196,919,000
- Profit/Loss
- EUR 7,779,000
- Equity
- EUR 98,523,000
- Total Assets
- EUR 494,720,000
- Employees
- 1,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.8B EUR | 196.9M EUR | 7.8M EUR | 98.5M EUR | 1590 |
| 2024 | 1.5B EUR | - | 17.6M EUR | 95.9M EUR | - |
| 2023 | 1.2B EUR | - | 20M EUR | 80.9M EUR | - |
| 2022 | 1B EUR | - | 5.8M EUR | 61M EUR | - |
| 2021 | 940.7M EUR | - | 415K EUR | 54.6M EUR | - |
Official annual report
How creditworthy is ABACUS MEDICINE A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.450.b" issued by Amgros I/S worth 72,960,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.791.b" issued by Amgros I/S worth 95,885,483 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.708.b" issued by Amgros I/S worth 321,891,182 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.611.b" issued by Amgros I/S worth 393,543,912 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.
About ABACUS MEDICINE A/S
ABACUS MEDICINE A/S is a Danish company of the type Aktieselskab based in København V, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ABACUS MEDICINE ApS. The management consists of Flemming Wagner. The board consists of Jens Albert Harsaae (chair), Alette Margaretha Verbeek, Anders Kunze Bønding and Flemming Wagner. The company is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB. The company has 388 employees (2026). In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. Equity in the 2025 report amounted to EUR 98,523,000.